Aruglim-M
• Management Of Type 2Dm & HbA IC Control
• Combination Therapy is Highly Beneficial in Type 2DM-High Secondary Failure Due To Monotherapy
Together achieves optimal control
Description
In the Management of T2DM and For Aggressive HbA1C Control
